Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01195_DB08893_nanopub.RAOG2MwrFTIP6ay1aaNQFrc0n6eOnfa7Zy_a6vqUaHiQY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01195_DB08893 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01195_DB08893 label "DDI between Flecainide and Mirabegron - Mirabegron is a moderate CYP2D6 inhibitor and may cause an increase in exposure of CYP2D6 substrates. Monitor concomitant therapy closely. [drugbank_resource:DB01195_DB08893]" assertion.
- drugbank_resource:DB01195_DB08893 identifier "drugbank_resource:DB01195_DB08893" assertion.
- drugbank_resource:DB01195_DB08893 title "DDI between Flecainide and Mirabegron - Mirabegron is a moderate CYP2D6 inhibitor and may cause an increase in exposure of CYP2D6 substrates. Monitor concomitant therapy closely." assertion.
- drugbank:DB08893 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01195_DB08893 assertion.
- drugbank:DB01195 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01195_DB08893 assertion.